Join Joselin Linder, author of “The Family Gene”, and Jodyn Platt, assistant professor in the U-M Medical School in a panel discussion about the ethical, legal, and social implications of genetics and newborn screening. The conversation will be moderated by Kayte Spector-Bagdady, assistant professor in the U-M Medical School and chief of the research ethics service in the Center for Bioethics and Social Sciences in Medicine.
Error messageThe page you requested does not exist. For your convenience, a search was performed using the query news events news 2017 03 30.
Page not found
Sarah Hawley and co-authors, David Miller and Megan Haymart, recently discussed their New England Journal of Medicine perspective piece, "Active Surveillance for Low-Risk Cancers — A Viable Solution to Overtreatment?" in an MHealth Lab interview. They discuss whether active surveillance — close monitoring without immediate treatment — could reduce overtreatment for some thyroid, prostate and breast cancer patients.
A new study finds that more than half of women with early stage breast cancer consider an aggressive surgery to remove both breasts. The way women generally approach big decisions, combined with their values, affects which breast cancer treatment they think about, the study also found.
CBSSM members, Sarah Hawley and Reshma Jagsi, were authors on this study.
Dean Shumway, Rochelle Jones, Sarah Hawley, and Reshma Jagsi are co-authors of a study, published in the Annals of Surgical Oncology, which found that clinician attitudes and patient expectations are driving overtreatment of radiotherapy in older breast cancer patients.
A study on surgeon influence on double mastectomy co-authored by Sarah Hawley and Reshma Jagsi was recently highlighted in Time Health. This study found that attending surgeons exerted a substantial amount of influence on the likelihood of receipt of contralateral prophylactic mastectomy after a breast cancer diagnosis. Steven Katz was first author of this study.
Sarah Hawley, Brian Zikmund-Fisher, and Reshma Jagsi are co-authors of a recent study published in Medical Decision Making, which was highlighted in MHealth Lab. Their study found that talking to clinicians is the best way for breast cancer patients to understand their recurrence risk. They also found that clinician discussions about recurrence risk should address uncertainty and the relevance of family and personal history. Kamaria Lee is first author of the article.
In an editorial in Nature Human Behaviour, Brian Zikmund-Fisher discusses the findings of a recent study about the unintended consequences of argument dilution in direct-to-consumer drug advertising. In a series of experiments, study authors, Niro Sivanathan and Hemant Kakker found that long lists of serious and minor side effects found in drug advertisements actually "dilute" consumers' judgments of the overall risk from side effects.
In a new analysis in Health Affairs, CBSSM's Jeffrey Kullgren and fellow researchers found that while the "Choosing Wisely" campaign to reduce overtesting and overtreatment is off to a strong start, more work is still needed to cut back on low-value care.
Jan Van den Bulck, PhD
Professor, Communication Studies
"Are the media (re-)defining how we interact with each other and with the world?
We know everything there is to know about people we have never even met. Through social media, we follow their every move. We even know their pets. Our media use interferes with healthy sleep, family meals, or even our work. Our children need levels of self-control to manage distractions that threaten their schoolwork. Or do they?"
In a study published in JAMA Internal Medicine, Jeff Kullgren and co-authors found that few individuals enrolled in High-Deductible Health Plans (HDHPs) in the United States are engaging in consumer behaviors.